Antibiotic Resistance: A global menace to human health

Abstract

1. Venessa K.S. Briceno. Superbug me: the FDA’s role in the fight against antibiotic resistance. Legislation And Public Policy. 2005;9:521-533
2. Sandegren L. Selection of antibiotic resistance at very low antibiotic concentrations. Upsala Journal of Medical Sciences. 2014; Early Online, 1–5.
3. Nutankalva L and Bharath HS. Menace of antibiotic resistance: Is this the end or is there a way out ? The Indian Practitioner 2014;67: 229
4. Alka Rani Chauhan and Narang P “Detection of extremely drug resistant(XDR) strains amongst the multi -drug resistant (MDR) mycobacterium tuberculosis isolates processed in a tertiary care hospital in central India” MD Thesis in Microbiology submitted to Mahrashtra University of Medicajl Sciences (MUHS).
5. Katiyar S K, Bihari S, Arun S, and Rawat T An analysis of failure of category DOTS II therapy. Indian J Community Med. 2008; 33: 129–130.
6. Yashodhara BM , Choo Beng Huat, Naik L N , Umakanth S , Hande M , Pappachan J M Multidrug and extensively drug-resistant tuberculosis from a general practice perspective. Infect Drug Resist. 2010; 3: 115–122.
7. Calligaro GL, Moodley L, Symons G, Dheda, K The medical and surgical treatment of drug resistant tuberculosis. J Thorac Dis. 2014; 6: 186–195.
8. Lange C, Abubakar I, Alffenaar J-W C, Bothamley G, Caminero JA., Carvalho ACC et al. Management of patients with multidrug-resistant/extensively drugresistant tuberculosis in Europe: a TBNET consensus statement ERJ Express. Published on March 23, 2014 as doi: 10.1183/09031936.00188313
9. Mendiratta DK Antifungal agents & susceptibility testing The Indian Practitioner 2014;67: 196
10. Zorzet A. Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Upsala Journal of Medical Sciences. 2014; Early Online, 1–6.
11. Schaberle TF and Hack I M. Overcoming the current deadlock in antibiotic research. Trends in Microbiology 2014; 22,: 165-167